151 related articles for article (PubMed ID: 10438939)
1. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.
Burger M; Burger JA; Hoch RC; Oades Z; Takamori H; Schraufstatter IU
J Immunol; 1999 Aug; 163(4):2017-22. PubMed ID: 10438939
[TBL] [Abstract][Full Text] [Related]
2. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway.
Burger M; Hartmann T; Burger JA; Schraufstatter I
Oncogene; 2005 Mar; 24(12):2067-75. PubMed ID: 15688008
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.
Arvanitakis L; Geras-Raaka E; Varma A; Gershengorn MC; Cesarman E
Nature; 1997 Jan; 385(6614):347-50. PubMed ID: 9002520
[TBL] [Abstract][Full Text] [Related]
6. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus.
Polson AG; Wang D; DeRisi J; Ganem D
Cancer Res; 2002 Aug; 62(15):4525-30. PubMed ID: 12154065
[TBL] [Abstract][Full Text] [Related]
7. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.
Gershengorn MC; Geras-Raaka E; Varma A; Clark-Lewis I
J Clin Invest; 1998 Oct; 102(8):1469-72. PubMed ID: 9788958
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant.
Schwarz M; Murphy PM
J Immunol; 2001 Jul; 167(1):505-13. PubMed ID: 11418689
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture.
Geras-Raaka E; Arvanitakis L; Bais C; Cesarman E; Mesri EA; Gershengorn MC
J Exp Med; 1998 Mar; 187(5):801-6. PubMed ID: 9480990
[TBL] [Abstract][Full Text] [Related]
10. Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Ho HH; Ganeshalingam N; Rosenhouse-Dantsker A; Osman R; Gershengorn MC
J Biol Chem; 2001 Jan; 276(2):1376-82. PubMed ID: 11031271
[TBL] [Abstract][Full Text] [Related]
11. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas.
Nador RG; Milligan LL; Flore O; Wang X; Arvanitakis L; Knowles DM; Cesarman E
Virology; 2001 Aug; 287(1):62-70. PubMed ID: 11504542
[TBL] [Abstract][Full Text] [Related]
12. HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks.
Vischer HF; Leurs R; Smit MJ
Trends Pharmacol Sci; 2006 Jan; 27(1):56-63. PubMed ID: 16352349
[TBL] [Abstract][Full Text] [Related]
13. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
Yang W; Schraw WP; Mueller SG; Richmond A
Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
[TBL] [Abstract][Full Text] [Related]
14. The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity.
Ho HH; Du D; Gershengorn MC
J Biol Chem; 1999 Oct; 274(44):31327-32. PubMed ID: 10531332
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
17. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Geras-Raaka E; Varma A; Ho H; Clark-Lewis I; Gershengorn MC
J Exp Med; 1998 Jul; 188(2):405-8. PubMed ID: 9670053
[TBL] [Abstract][Full Text] [Related]
18. Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling.
Lyngaa R; Nørregaard K; Kristensen M; Kubale V; Rosenkilde MM; Kledal TN
Oncogene; 2010 Aug; 29(31):4388-98. PubMed ID: 20543866
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
20. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.
Gao SJ; Boshoff C; Jayachandra S; Weiss RA; Chang Y; Moore PS
Oncogene; 1997 Oct; 15(16):1979-85. PubMed ID: 9365244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
